EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Small Molecule Kinase Inhibitors with In Vitro β‐Hematin Formation and Plasmodium falciparum Protein Kinase G Inhibitory Activity Identified Using Machine Learning

Jessica L Thibaud, Nicolaas Salomane, Sarah Harries, Kathryn J Wicht, Lauren B Coulson, David Kuter, Kelly Chibale, Katherine A de Villiers iD

ChemMedChem · 2026

DOI: 10.1002/cmdc.202500756 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2026. Verfasst von Jessica L Thibaud und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Polymer Science, Stellenbosch University, Stellenbosch, South Africa. Hauptthemen laut MEDLINE: Plasmodium falciparum, Machine Learning, Protein Kinase Inhibitors, Cyclic GMP-Dependent Protein Kinases. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, NIAID.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Using a combination of molecular docking and machine learning, the BioVision Protein Kinase Inhibitor library was screened for potential inhibitors with dual activity against two Plasmodium falciparum targets, β‐hematin (synthetic hemozoin) formation and cGMP‐dependent protein kinase ( Pf PKG). Three compounds with promising activity against both targets were identified. Derazantinib is the most potent hit compound with IC 50 values of 88 µM for inhibition of β‐hematin formation (compared to 22 μM for chloroquine) and 0.160 µM against Pf PKG. Pazopanib (β‐hematin IC 50 : 219 µM and Pf PKG IC 50 : 0.330 µM) and afatinib (234 and 2.61 µM, respectively) showed more moderate activity profiles against both targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasmodium falciparumMachine LearningProtein Kinase InhibitorsCyclic GMP-Dependent Protein KinasesHemeproteinsSmall Molecule LibrariesAntimalarialsMolecular Docking SimulationStructure-Activity RelationshipMolecular StructureDose-Response Relationship, Drug

Stichwörter der Autor:innen

antimalarialmachine learningpolypharmacologyprincipal component analysisβ‐hematin

Substanzen

Protein Kinase InhibitorshemozoinCyclic GMP-Dependent Protein KinasesHemeproteinsSmall Molecule LibrariesAntimalarials

Autor:innen und Institutionen

  • Department of Chemistry and Polymer Science, Stellenbosch University, Stellenbosch, South Africa.
  • Holistic Drug Discovery and Development Centre (H3D), University of Cape Town, Cape Town, South Africa.
  • Department of Chemistry, University of Cape Town, Cape Town, South Africa.
  • South African Medical Research Council Drug Discovery and Development Research Unit, Department of Chemistry and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • GenAIRx, Toronto, Ontario, Canada.

ORCID-Profile: Katherine A de Villiers

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • NIAID

Zitieren

APA

Thibaud, J. L., Salomane, N., Harries, S., Wicht, K. J., Coulson, L. B., Kuter, D., Chibale, K., & de Villiers, K. A. (2026). Small Molecule Kinase Inhibitors with In Vitro β‐Hematin Formation and Plasmodium falciparum Protein Kinase G Inhibitory Activity Identified Using Machine Learning. ChemMedChem. https://doi.org/10.1002/cmdc.202500756

Vancouver

Thibaud JL, Salomane N, Harries S, Wicht KJ, Coulson LB, Kuter D, et al. Small Molecule Kinase Inhibitors with In Vitro β‐Hematin Formation and Plasmodium falciparum Protein Kinase G Inhibitory Activity Identified Using Machine Learning. ChemMedChem. 2026. doi:10.1002/cmdc.202500756

BibTeX
@article{Thibaud2026,
  author = {Thibaud, Jessica L and Salomane, Nicolaas and Harries, Sarah and Wicht, Kathryn J and Coulson, Lauren B and Kuter, David and Chibale, Kelly and de Villiers, Katherine A},
  title = {Small Molecule Kinase Inhibitors with In Vitro β‐Hematin Formation and Plasmodium falciparum Protein Kinase G Inhibitory Activity Identified Using Machine Learning},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.202500756}
}
Kostenlos starten →